Bio-Rad Labs (BIO) Misses Q2 EPS by 52c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $368.75 -2.18%
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.61, $0.52 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $516.8 million versus the consensus estimate of $497.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Copart to buy ACV for $1.9 billion in cash deal
- JPMorgan Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
